Table 2 |
||||||
|
Simple linear regression analyses of factors associated with BDI-21 |
||||||
| 95% Confidence interval |
||||||
|
|
||||||
| Factor |
Unstandardized coefficient |
Lower bound |
Upper bound |
Standardized coefficients |
p Value |
R2 |
|
|
||||||
| Gender |
1.991 |
-0.036 |
4.018 |
0.136 |
0.054 |
0.018 |
| Seizure frequency > 1/month |
4.888 |
2.588 |
7.187 |
0.285 |
< 0.001 |
0.081 |
| Seizure frequency < 1/year |
-2.129 |
-4.305 |
0.046 |
-0.136 |
0.055 |
0.018 |
| Seizure frequency > 1/year |
-1.728 |
-3.773 |
0.317 |
-0.117 |
0.097 |
0.014 |
| Symptomatic focal epilepsy |
3.605 |
1.621 |
5.588 |
0.246 |
< 0.001 |
0.061 |
| Cryptogenic Focal Epilepsy |
-1.691 |
-3.973 |
0.591 |
-0.103 |
0.145 |
0.103 |
| Idiopathic generalized epilepsy |
-3.357 |
-5.806 |
-0.907 |
-0.188 |
0.007 |
0.035 |
| Antiepileptic drug 1 |
-2.523 |
-4.538 |
-0.508 |
-0.172 |
0.014 |
0.030 |
| Antiepileptic drug 1 |
1.064 |
-1.077 |
3.206 |
0.069 |
0.328 |
0.005 |
| Antiepileptic drug 1 |
3.065 |
0.227 |
5.904 |
0.149 |
0.034 |
0.022 |
| Age |
-0.040 |
-0.142 |
0.062 |
-0.054 |
0.443 |
0.003 |
| Duration of disease |
-0.036 |
-0.145 |
0.073 |
-0.046 |
0.516 |
0.002 |
Kimiskidis et al. Annals of General Psychiatry 2007 6:28 doi:10.1186/1744-859X-6-28 |
||||||
